Eva Ho
Directeur Financier/CFO chez Crown Bioscience, Inc.
Profil
Eva Ho is currently the Chief Financial Officer at Crown Bioscience, Inc. She previously worked as the Chief Financial Officer & Spokesman at Acer, Inc. from 2012 to 2014.
She also held the position of Chief Financial Officer & Vice President at Test Rite International Co., Ltd.
and Chief Financial Officer at TWi Pharmaceuticals, Inc. Ms. Ho's education includes an MBA from the University of Denver and an undergraduate degree from National Taiwan University.
Postes actifs de Eva Ho
| Sociétés | Poste | Début |
|---|---|---|
Crown Bioscience, Inc.
 Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Directeur Financier/CFO | 30/08/2016 |
Anciens postes connus de Eva Ho
| Sociétés | Poste | Fin |
|---|---|---|
| ACER INCORPORATED | Directeur Financier/CFO | 01/05/2014 |
| CROWN BIOSCIENCE INTERNATIONAL | Directeur Financier/CFO | - |
| TWI PHARMACEUTICALS INC | Directeur Financier/CFO | - |
| TEST-RITE INTERNATIONAL CO., LTD. | Directeur Financier/CFO | - |
Formation de Eva Ho
| National Taiwan University | Undergraduate Degree |
| University of Denver | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| TEST-RITE INTERNATIONAL CO., LTD. | Distribution Services |
| ACER INCORPORATED | Electronic Technology |
| Entreprise privées | 3 |
|---|---|
TWi Pharmaceuticals, Inc.
 TWi Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TWi Pharmaceuticals, Inc. operates as a technology-based special pharmaceutical company. The firm engages in the development and commercialization of high barrier generics drugs. Its products include donepezil hydrochloride tablets, megestrol acetate oral suspension, hydroquinone cream, guanfacine extended-release tablets and nifedipine extended-release tablets. The company was founded by Chih Ming Chen on December 1, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
Crown Bioscience, Inc.
Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Commercial Services |
Crown Bioscience International
 Crown Bioscience International BiotechnologyHealth Technology Crown Bioscience International develops drug for Oncology and Metabolic Diseases. Its products include Antibodies for in vivo & in vitro studies, Tissues for CVMD research and therapeutic R&D, Recombinant cell lines, Tumor samples for oncology research & drug development. The company founded on October 22, 2013 and is headquartered in Taipei, Taiwan. | Health Technology |